Home About Us Technologies Investor Relations News Contact Flex Biomedical - In the News Flex Biomedical raises nearly $1 million and moves to WI August 14, 2009 - Flex Biomedical, Inc., a privately-held orthopedics company focused on developing novel treatments and diagnostics for orthopedic diseas...

Home About Us Technologies Investor Relations News Contact About Flex Biomedical - Advisors Mark Grinstaff, PhD - Dr. Grinstaff, a Flex Bio cofounder, is Associate Professor of Biomedical Engineering and Chemistry at Boston University. Prior to BU Mark was Assistant Professor of Chemistry, Ophthalmo...

Home About Us Technologies Investor Relations News Contact Contact Flex Biomedical Flex Biomedical, Inc. Madison, WI Email: admin@flexbio.com Website: www.flexbio.com Total market for products to treat Osteoarthritis (OA) is currently more than $5billion. Will rise to $7billion by 2015. 2010 Flex ...

Home About Us Technologies Investor Relations News Contact About Flex Biomedical - Management Team Michel Wathier, PhD - Vice President of Research & Development. Michel was a Project Manager in the Grinstaff lab in the departments of Biomedical Engineering and Chemistry at Boston University. He...

Home About Us Technologies Investor Relations News Contact Investor Relations - Executive Summary Flex Biomedical, Inc. develops and commercializes innovative products for the treatment and diagnosis of orthopedic injuries and diseases. Flex Biomedical's lead product is a synthetic polymer, the Flex...